As expected, in this work, anti-CD47 antibody (CC2C6) showed strong binding and hemagglutination with RBCs, whereas the phenomena of anti-CD47 nanobodies hu404 were negligible (Fig. 2E-F); meanwhile, hu404-hFc fusion still maintain the binding ability to tumor cells (Fig. 2G). Here, CD47 is linked to neoplasm.